Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice
- 1 February 2003
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 462 (1-3) , 125-132
- https://doi.org/10.1016/s0014-2999(03)01343-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerolBritish Journal of Pharmacology, 2002
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Complex regional haemodynamic effects of anandamide in conscious ratsBritish Journal of Pharmacology, 2002
- Anandamide administration into the ventromedial hypothalamus stimulates appetite in ratsBritish Journal of Pharmacology, 2001
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Structure−Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor AntagonistsJournal of Medicinal Chemistry, 1999
- Hyperphagia in pre-fed rats following oral δ9-THCPublished by Elsevier ,1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptorsLife Sciences, 1997
- Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratoryAppetite, 1988